Ten Alzheimer's disease patients underwent a trial of oral
tetrahydroaminoacridine (THA) and lecithin. After 3 inpatient weeks there
was no clear therapeutic effect. Three of six patients able to continue in
long-term treatment showed measurable cognitive improvement, but only one
displayed clinically obvious improvement.
Abstract Teaser